Adriána Kutás
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Adriána Kutás has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Attila Garami
Institute of Energy, Ceramic and Polymer Technology, University of Miskolc, 3515 Miskolc, Hungary
3 shared publications - Csaba Váradi
Institute of Chemistry, Faculty of Materials Science and Chemical Engineering, University of Miskolc, 3515 Miskolc, Hungary
3 shared publications - Béla Viskolcz
Higher Education and Industrial Cooperation Centre, University of Miskolc, 3515 Miskolc, Hungary
2 shared publications - Béla Demeter
Institute of Chemistry, Faculty of Materials Science and Chemical Engineering, University of Miskolc, 3515 Miskolc, Hungary
1 shared publication - Csaba Oláh
Doctoral School of Health Sciences, University of Debrecen, Egyetem tér 1, 4028 Debrecen, Hungary
1 shared publication - Edina Petercsák
Borsod-Abaúj-Zemplén County Center Hospital and University Teaching Hospital, Department of Neurosurgery, 3526 Miskolc, Hungary
1 shared publication
Latest Publications
- Open Access
- 20 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 2010
Longitudinal Profiling of Plasma N-Glycomic Alterations in an STZ-Induced Mouse Model of Hyperglycemia
The rising global incidence of Type 1 Diabetes Mellitus (T1DM) necessitates a deeper understanding of the molecular shifts underlying its metabolic complications, specifically the role of protein N-glycosylation. This study utilized a streptozotocin-induced C57Bl/6 mouse model to examine temporal changes in plasma N-glycan profiles at 2, 8, and 20 weeks post-induction using HILIC-UPLC-FLR-MS. Following the successful establishment of persistent hyperglycemia and weight loss, glycomic analysis revealed significant structural remodeling of 20 individual glycan species, with complex, multi-sialylated structures proving most sensitive to disease progression. Notably, bi-antennary structures such as A2G1S1, A2G2S1, and A2G2S2(2) exhibited a marked decrease in relative abundance that strongly correlated with elevated blood glucose levels. In contrast, highly sialylated and fucosylated glycans like FA2G2S3 and FA3G3S3 showed a progressive increase over the 20-week period, suggesting an adaptive response to chronic metabolic stress and altered hepatic processing. Our findings demonstrate that chronic hyperglycemia is accompanied by substantial remodeling of the plasma N-glycome, characterized by increased sialylation and fucosylation. These alterations closely track the progression of metabolic dysregulation, suggesting that while they parallel blood glucose trends, they provide a distinct molecular readout of the systemic glycosylation response to glucotoxicity. This study offers a detailed longitudinal characterization of these glycomic changes, highlighting their potential value as descriptive markers of cumulative metabolic stress in rodent models of type 1 diabetes.
- 20 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 2010
Open AccessLongitudinal Profiling of Plasma N-Glycomic Alterations in an STZ-Induced Mouse Model of Hyperglycemia
The rising global incidence of Type 1 Diabetes Mellitus (T1DM) necessitates a deeper understanding of the molecular shifts underlying its metabolic complications, specifically the role of protein N-glycosylation. This study utilized a streptozotocin-induced C57Bl/6 mouse model to examine temporal changes in plasma N-glycan profiles at 2, 8, and 20 weeks post-induction using HILIC-UPLC-FLR-MS. Following the successful establishment of persistent hyperglycemia and weight loss, glycomic analysis revealed significant structural remodeling of 20 individual glycan species, with complex, multi-sialylated structures proving most sensitive to disease progression. Notably, bi-antennary structures such as A2G1S1, A2G2S1, and A2G2S2(2) exhibited a marked decrease in relative abundance that strongly correlated with elevated blood glucose levels. In contrast, highly sialylated and fucosylated glycans like FA2G2S3 and FA3G3S3 showed a progressive increase over the 20-week period, suggesting an adaptive response to chronic metabolic stress and altered hepatic processing. Our findings demonstrate that chronic hyperglycemia is accompanied by substantial remodeling of the plasma N-glycome, characterized by increased sialylation and fucosylation. These alterations closely track the progression of metabolic dysregulation, suggesting that while they parallel blood glucose trends, they provide a distinct molecular readout of the systemic glycosylation response to glucotoxicity. This study offers a detailed longitudinal characterization of these glycomic changes, highlighting their potential value as descriptive markers of cumulative metabolic stress in rodent models of type 1 diabetes.
- Open Access
- 18 January 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (2) , 946
The Impact of IgG Glycosylation in SARS-CoV-2 Infection vs. Vaccination: A Statistical Analysis
This study investigates the glycosylation patterns of serum IgG antibodies in relation to COVID-19 infection and vaccination, highlighting the potential of specific glycan profiles as biomarkers for immune responses. Using Spearman correlation analysis, distinct associations among glycan levels and various clinical laboratory parameters were identified, revealing complex, non-linear interactions that influence immune dynamics. Significant differences were observed in sialylated glycan profiles across patient groups, indicating that vaccination and natural infection elicit unique immune mechanisms and suggesting that vaccination induces favorable glycosylation changes. Notably, high-mannose glycans were found to correlate with other glycan types, underscoring their critical role in the immune response and suggesting their potential as biomarkers to differentiate between infection- and vaccination-induced immunity. The findings suggest that understanding these glycosylation dynamics may enhance diagnostic and therapeutic strategies, providing valuable tools for differentiating between immune responses elicited by infection and vaccination. Overall, this study contributes to the understanding of glycosylation’s impact on immune function in the context of COVID-19, emphasizing the importance of specific glycan markers, such as sialylated and high-mannose structures, in clinical applications.
- 18 January 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (2) , 946
Open AccessThe Impact of IgG Glycosylation in SARS-CoV-2 Infection vs. Vaccination: A Statistical Analysis
This study investigates the glycosylation patterns of serum IgG antibodies in relation to COVID-19 infection and vaccination, highlighting the potential of specific glycan profiles as biomarkers for immune responses. Using Spearman correlation analysis, distinct associations among glycan levels and various clinical laboratory parameters were identified, revealing complex, non-linear interactions that influence immune dynamics. Significant differences were observed in sialylated glycan profiles across patient groups, indicating that vaccination and natural infection elicit unique immune mechanisms and suggesting that vaccination induces favorable glycosylation changes. Notably, high-mannose glycans were found to correlate with other glycan types, underscoring their critical role in the immune response and suggesting their potential as biomarkers to differentiate between infection- and vaccination-induced immunity. The findings suggest that understanding these glycosylation dynamics may enhance diagnostic and therapeutic strategies, providing valuable tools for differentiating between immune responses elicited by infection and vaccination. Overall, this study contributes to the understanding of glycosylation’s impact on immune function in the context of COVID-19, emphasizing the importance of specific glycan markers, such as sialylated and high-mannose structures, in clinical applications.
- Open Access
- 5 January 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 552
Differential Glycosylation Patterns in Parkinson’s Disease: Emphasis on Male-Specific Changes Identified via HILIC-LC-MS
Parkinson’s disease (PD) is a progressive neurodegenerative disorder primarily characterized by the degeneration of dopaminergic neurons, leading to significant motor and non-motor symptoms. This study investigates glycosylation patterns with a significant emphasis on male Parkinson’s Disease (PD) patients, revealing unique alterations distinguishing PD from healthy states, utilizing high-performance liquid chromatography coupled with mass spectrometry (HILIC-LC-MS). Findings reveal significantly altered serum N-glycosylation profiles between male and female patients, with increased levels of high-mannose glycans and reduced mono-sialylated glycans in male patients. ROC curve analysis indicates that these glycan changes are the most important features for distinguishing PD from healthy states, with AUC values of 0.71 for M5 and 0.85 for M6. This study underscores the critical role of glycosylation in the pathophysiology of Parkinson’s disease and highlights its potential in early detection and monitoring of disease progression.
- 5 January 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 552
Open AccessDifferential Glycosylation Patterns in Parkinson’s Disease: Emphasis on Male-Specific Changes Identified via HILIC-LC-MS
Parkinson’s disease (PD) is a progressive neurodegenerative disorder primarily characterized by the degeneration of dopaminergic neurons, leading to significant motor and non-motor symptoms. This study investigates glycosylation patterns with a significant emphasis on male Parkinson’s Disease (PD) patients, revealing unique alterations distinguishing PD from healthy states, utilizing high-performance liquid chromatography coupled with mass spectrometry (HILIC-LC-MS). Findings reveal significantly altered serum N-glycosylation profiles between male and female patients, with increased levels of high-mannose glycans and reduced mono-sialylated glycans in male patients. ROC curve analysis indicates that these glycan changes are the most important features for distinguishing PD from healthy states, with AUC values of 0.71 for M5 and 0.85 for M6. This study underscores the critical role of glycosylation in the pathophysiology of Parkinson’s disease and highlights its potential in early detection and monitoring of disease progression.